EPAC1 Pharmacological Inhibition with AM-001 Prevents SARS-CoV-2 and Influenza A Virus Replication in Cells

EPAC1 Pharmacological Inhibition with AM-001 Prevents SARS-CoV-2 and Influenza A Virus Replication in Cells

The exceptional impact of the COVID-19 pandemic has stimulated an intense search for antiviral molecules. Host-targeted antiviral molecules have the potential of presenting broad-spectrum antiviral activity and are also considered as less likely to select for resistant viruses. In this study, we inv...

Full description

Bibliographic Details
Main Authors: Charlotte Foret-Lucas, Thomas Figueroa, Alexandre Bertin, Pierre Bessière, Alexandre Lucas, Dorian Bergonnier, Marine Wasniewski, Alexandre Servat, Arnaud Tessier, Frank Lezoualc’h, Romain Volmer
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Viruses
Subjects:
SARS-CoV-2
influenza A
host-targeted antiviral
EPAC1 inhibitor
cylic AMP
Online Access:https://www.mdpi.com/1999-4915/15/2/319

Internet

https://www.mdpi.com/1999-4915/15/2/319

Similar Items